A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...
Lumacyte CEO on how real-time insight is driving down manufacturing failures and opening doors for more patients.
The AMT designation gives Cellares’ clients using the Cell Shuttle priority review with the FDA leading to accelerated regulatory filings SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the ...
The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...
CAR-T therapies have proven their curative potential, but cell therapy developers continue to face challenges related to manufacturing complexities, costs, scalability, regulatory compliance, and ...
Avantor AVTR recently entered into a strategic partnership with BlueWhale Bio to accelerate innovation in CAR-T cell therapy manufacturing. The collaboration merges Avantor’s bioprocessing expertise ...
PRINCETON, N.J. and CHICAGO, Sept. 30, 2025 /PRNewswire/ -- Made Scientific, a leading cell therapy contract development and manufacturing organization (CDMO) and Syenex, a synthetic biology company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback